MVF-HER2 266-296 and MVF HER2 597-626 peptide vaccines (Indiana University Melvin & Bren Simon Comprehensive Cancer Center)

N/A

Report date: 2026/04/23 20:00:25

Base Information

Drug NameMVF-HER2 266-296 and MVF HER2 597-626 peptide vaccines (Indiana University Melvin & Bren Simon Comprehensive Cancer Center)
Drug Alias NameN/A
ClassificationVaccines > Development/production technology > Synthetic peptide vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesIndiana University Melvin And Bren Simon Cancer Center
China Registration ClassN/A

Develop Information

Active CompaniesIndiana University Melvin And Bren Simon Cancer Center
Inactive CompaniesN/A
Active IndicationsBreast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A